Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical practice guidelines. Treatment of schizophrenia.

Literature DB >> 16529334

Clinical practice guidelines. Treatment of schizophrenia.

Abstract

Entities: Disease

Mesh：

Substances：
Antipsychotic Agents

Year: 2005 PMID： 16529334

Source DB: PubMed Journal: Can J Psychiatry ISSN： 0706-7437 Impact factor: 4.356

Keyword Cloud
Cited

× No keyword cloud information.

62 in total

1. Clozapine: a distinct, poorly understood and under-used molecule.

Authors: Ridha Joober; Patricia Boksa
Journal: J Psychiatry Neurosci Date: 2010-05 Impact factor: 6.186

2. Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study.

Authors: Delbert G Robinson; Nina R Schooler; Majnu John; Christoph U Correll; Patricia Marcy; Jean Addington; Mary F Brunette; Sue E Estroff; Kim T Mueser; David Penn; James Robinson; Robert A Rosenheck; Joanne Severe; Amy Goldstein; Susan Azrin; Robert Heinssen; John M Kane
Journal: Am J Psychiatry Date: 2014-12-04 Impact factor: 18.112

Review 3. Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

Authors: Constantin Tranulis; Leila Skalli; Pierre Lalonde; Luc Nicole; Emmanuel Stip
Journal: Drug Saf Date: 2008 Impact factor: 5.606

4. Effectiveness of antipsychotics: is the CATIE trial a tsunami?

Authors: Emmanuel Stip; Karyne Anselmo
Journal: Can Fam Physician Date: 2007-01 Impact factor: 3.275

Review 5. Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis.

Authors: Joseph H Puyat; Jamie R Daw; Colleen M Cunningham; Michael R Law; Sabrina T Wong; Devon L Greyson; Steven G Morgan
Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2013-08-14 Impact factor: 4.328

6. Cross-sectional comparison of first-generation antipsychotic long-acting injections vs risperidone long-acting injection: patient-rated attitudes, satisfaction and tolerability.

Authors: Sourabh Moti Singh; Peter M Haddad; Nusrat Husain; Eamonn Heaney; Barbara Tomenson; Imran B Chaudhry
Journal: Ther Adv Psychopharmacol Date: 2016-03-10

Clinical practice guidelines. Treatment of schizophrenia.

1. Clozapine: a distinct, poorly understood and under-used molecule.

2. Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study.

Review 3. Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

4. Effectiveness of antipsychotics: is the CATIE trial a tsunami?

Review 5. Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis.

6. Cross-sectional comparison of first-generation antipsychotic long-acting injections vs risperidone long-acting injection: patient-rated attitudes, satisfaction and tolerability.

7. Trends in adult antipsychotic polypharmacy: progress and challenges in Florida's Medicaid program.

Review 8. The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

9. Five Year Outcomes of Tapering Antipsychotic Drug Doses in a Community Mental Health Center.

10. Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting.